Emanuela Tafi Selected Research

Ospemifene

10/2016

Pharmacokinetics, pharmacodynamics and clinical efficacy of ospemifene for the treatment of dyspareunia and genitourinary syndrome of menopause.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Emanuela Tafi Research Topics

Disease

4	Endometriosis 04/2017 - 03/2014
1	Breast Neoplasms (Breast Cancer) 10/2016
1	Dyspareunia 10/2016
1	Leiomyoma (Uterine Fibroids) 06/2015
1	Dysmenorrhea (Menstrual Pain) 01/2015
1	Chronic Disease (Chronic Diseases) 01/2015
1	Overactive Urinary Bladder (Overactive Bladder) 11/2013

Drug/Important Bio-Agent (IBA)

2	Estrogens (Estrogen)FDA Link 10/2016 - 01/2015
2	Progestins (Progestagens)IBA 01/2015 - 09/2014
1	sperm releasing substanceIBA 04/2017
1	Selective Estrogen Receptor Modulators (SERM)IBA 10/2016
1	OspemifeneIBA 10/2016
1	Progesterone FDA LinkGeneric 06/2015
1	ulipristal acetate FDA Link 06/2015
1	Oral ContraceptivesIBA 01/2015
1	Aromatase InhibitorsIBA 01/2015
1	elagolixIBA 01/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2015
1	drospirenone FDA LinkGeneric 01/2015
1	Combined Oral ContraceptivesIBA 01/2015
1	dienogest FDA Link 09/2014
1	Nandrolone (Nortestosterone)IBA 09/2014
1	Desogestrel FDA LinkGeneric 03/2014
1	Contraceptive Agents (Contraceptives)IBA 03/2014
1	Muscarinic AntagonistsIBA 11/2013

Therapy/Procedure

4	Therapeutics 10/2016 - 11/2013
1	Drug Therapy (Chemotherapy) 01/2015
1	Female Contraceptive Devices (Vaginal Ring) 03/2014